Latest Macular degeneration Stories
New study shows that the Diopsys NOVA-ERG acts as window to the brain Pine Brook, NJ (PRWEB) October 09, 2014 Research scientists from the University
HUNTINGTON, N.Y., Oct.
-- Fourth indication for injection treatment that can stabilize and improve vision(1) -- mCNV a leading cause of visual impairment among those 20-50 years of age(9) Since
EYLEA Now Approved for Wet Age-related Macular Degeneration (AMD), Diabetic Macular Edema (DME), and Macular Edema following RVO TARRYTOWN, N.Y., Oct.
SAN DIEGO, Sept.
Vast majority of adults are not getting enough of two nutrients crucial for vision PARSIPPANY, N.J., Sept.
NEW YORK, September 22, 2014 /PRNewswire/ -- Persistence Market Research (http://www.persistencemarketresearch.com) Released New Market Report on "Global Market Study on
TARRYTOWN, N.Y., Sept. 22, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd.
Fovista and Abicipar Pegol Will Need to be Priced Competitively to Current Agents to Garner Favorable Tier Placement, According to Findings from Decision Resources Group BURLINGTON, Mass.,
ST. LOUIS, Sept. 16, 2014 /PRNewswire/ -- According to the American Academy of Ophthalmology, September is Healthy Aging Month.
- Growing in low tufty patches.